Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profiles
Tumour samples are heterogeneous and are comprised of multiple cell types in addition to cancer cells. Here, the authors devised a method to estimate the relative levels of haematopoietic cells in breast cancer samples and demonstrate that this correlates with prognosis.
Main Authors: | Frederick S. Varn, Erik H. Andrews, David W. Mullins, Chao Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2016-01-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms10248 |
Similar Items
-
Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapy
by: Frederick S. Varn, et al.
Published: (2018-06-01) -
Regulators associated with clinical outcomes revealed by DNA methylation data in breast cancer.
by: Matthew H Ung, et al.
Published: (2015-05-01) -
The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients
by: Kenneth M. K. Mark, et al.
Published: (2017-05-01) -
A B cell-derived gene expression signature associates with an immunologically active tumor microenvironment and response to immune checkpoint blockade therapy
by: Frederick S. Varn, et al.
Published: (2019-01-01) -
Haematopoietic Serine Proteases : A Cleavage Specificity Analysis
by: Thorpe, Michael
Published: (2014)